Undoing Medicine's Male Bias
When we look back at the cultural milestones of the last decade, the world appears unmistakably modern. Popular culture was already producing globally celebrated female icons like Frozen’s Elsa, signaling progress in how women were represented and imagined. Yet, inside the quieter corridors of scientific research, a far more basic correction was still overdue. For decades, medical science operated on a rigid male-as-default model. It was only in 2016, three years after Frozen premiered, that the National Institutes of Health mandated the inclusion of female cells and animals in preclinical studies. Until then, male biology dominated drug testing and disease modeling, producing a deep and systematic gap in our understanding of female biology.
Modern Marvels and Outdated Medicine
The speed of entertainment often veils the reality of stagnation of gender justice in the laboratory. Consider the timeline of the internet: the World Wide Web was made public in 1991, yet the medical community was still years away from legally requiring the inclusion of women in trials, mandated in 1993. The comparison becomes even more absurd when compared to space travel. We successfully reached the moon in 1969, but it took until Thor’s theatrical debut in 2011, for the medical community to widely acknowledge that women experience different heart attack symptoms than men.
While our superheroes were perfecting 3D-holographic interfaces, female surgeons were still struggling with tools designed for hands significantly larger than their own. This “male-as-default” model led to dangerous outcomes in pharmaceutical safety. In 1977, the Food and Drug Administration (FDA) issued a guideline that banned women of “childbearing potential” from participating in early-phase research. This created a world where drugs were tested on men and then prescribed to women. For twenty years, the sleep medication Ambien was prescribed at the same dosage for both sexes. It was only in 2013 that the FDA realized women metabolize the active ingredient much slower than men. By the time we had iPhones and social media, we still did not have accurate dosage instructions for women.
Innovation Without Biological Inclusion
The innovation paradox continues today within digital health and medical hardware. The first artificial heart was implanted in 1982, but it was physically too large for 88% of women. It took until the 2020s to design a version that fits the average female chest. Even crash test dummies have historically been modeled after the average male stature. This means that while we were developing self-driving cars and high-definition streaming, women were still 73% more likely to be injured in a car crash. The technology exists to map the stars, yet the medical industry has struggled to calibrate its most basic tools for more than half the population.
Rewriting the Medical Blueprint
While recent regulatory shifts have begun to address the historical exclusion of female biology, we are still navigating the wake of a medical landscape built on a singular, masculine blueprint. This “standard human” model treated female physiology as a deviation, or worse, a complication,rather than a primary pillar of scientific inquiry. The result is a persistent knowledge vacuum that extends far beyond a few policy changes; it is embedded in the very way we train clinicians, design diagnostic tools, and formulate public health strategies.
True progress requires more than just retrofitting data into an old system. It demands a fundamental redesign of how we define medical “normality.” Until our research protocols and clinical practices consistently account for the distinct hormonal, cellular, and physiological realities of every body, the promise of personalized medicine remains an unfinished project. We are moving toward a future where health is no longer a matter of conforming to a male-centric myth, but one where the science is as diverse as the people it is meant to heal.
References
- National Institutes of Health. (2014). NIH Announces New Policies to Mandate Inclusion of Female Cells. https://rethinkingclinicaltrials.org/news/nih-announces-new-policies-to-mandate-inclusion-of-female-cells-and-animals-in-preclinical-research/
- American Heart Association. (2024). The slowly evolving truth about heart disease and women. https://www.heart.org/en/news/2024/02/09/the-slowly-evolving-truth-about-heart-disease-and-women
- Stanford University. (2025). Medical Technology: Intersectional Approaches. http://genderedinnovations.stanford.edu/case-studies/medtech.html
Author
